ZYDUSLIFE Zydus Lifesciences Ltd Disruption of operations due to natural disasters, accidents, or other events Announcement 2023 - US FDA Inspection Zydus Lifesciences Ltd received final approval from the USFDA for Oxcarbazepine Tablets USP, 150 mg, 300 mg and 600 mg..Find Corporate Announcements for Press Releases, AGM, Insider Trading & SAST, Results and Corporate Action for Zydus Lifesciences Ltd